← Back to Clinical Trials
Recruiting NCT02359812

NCT02359812 Robot Aided Rehabilitation - Multi-joint Evaluations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02359812
Status Recruiting
Phase
Sponsor University of Maryland, Baltimore
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 56 participants
Start Date 2018-05-07
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 56 participants in total. It began in 2018-05-07 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Sensory and motor impairments following stroke can lead to substantial disability involving the arm and hand. The investigator hypothesized that excessive local and cross-coupled stiffness, diminished individuation and proprioceptive acuity will be present among multiple degree of freedom in the upper limb. The stiffness and spasticity will increase with time post-stroke. The objective of this study is to quantify the progression throughout the arm and hand during recovery from stroke. The investigator will measure the clinical assessment scores, and neuromechanical properties including range of motion, active and passive cross coupling, and spasticity by the IntelliArm robot.

Eligibility Criteria

Inclusion Criteria: 1. First focal unilateral lesion, ischemic or hemorrhagic 2. Had a stroke less than a month prior to enrollment 3. Rated between stages 1-4 on the Chedoke McMaster Stroke Assessment Impairment Inventory: Stage of Recovery of the Arm 4. Rated between stages 1-4 on the Chedoke McMaster Stroke Assessment Impairment Inventory: Stage of Recovery of the Hand Exclusion Criteria: 1. Apraxia 2. Other unrelated or musculoskeletal injuries 3. Unable to sit in a chair for 3 consecutive hours 4. Score of less than 22 on the Mini Mental Status Exam 5. Poor fit into equipment used in study which compromises proper use. This will be determined by the judgment of study staff

Contact & Investigator

Central Contact

Soh-Hyun Hur, B.S.

✉ sohur@som.umaryland.edu

📞 (410) 706-1625

Principal Investigator

Li-Qun Zhang, Ph.D.

PRINCIPAL INVESTIGATOR

University of Maryland, Baltimore

Frequently Asked Questions

Who can join the NCT02359812 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02359812 currently recruiting?

Yes, NCT02359812 is actively recruiting participants. Contact the research team at sohur@som.umaryland.edu for enrollment information.

Where is the NCT02359812 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT02359812 clinical trial?

NCT02359812 is sponsored by University of Maryland, Baltimore. The principal investigator is Li-Qun Zhang, Ph.D. at University of Maryland, Baltimore. The trial plans to enroll 56 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology